Space Warlord Baby Trading Simulator
Strange Scaffold · 2026 · $19.99 · Simulation · deal grade B
Measured on 2026-10-05 15:38 UTC. The whole catalog is re-measured daily; a game that just launched can move fast between passes.
- Estimated net residual revenue: $2.0k to $3.1k per month
- Opportunity: $3.3k per month at x1.30 dormancy
- Estimated lifetime owners: 20.7k
- 91% positive across 545 reviews · 15.2 reviews/month
Why it's flagged
- Developer active, last post 2 months ago
- Studio active elsewhere (8 titles tracked), so this one may welcome a partner
- Store page localized in only 1 language(s)
- Last discounted 0 months ago, 8 sales in the last 12 months
Analyst notes (AI-assisted)
Note written 2026-08-30; the live figures above take precedence over any numbers in it.
A roguelike financial-sim where you trade on the life outcomes of alien babies, blending dark-comedy premise with addictive stock-trading mechanics.
Space Warlord Baby Trading Simulator occupies a rare niche: mechanically solid, extremely high review sentiment, and drawing steady residual revenue from a compact but engaged playerbase. The game's premise is deliberately absurdist; its execution is rigorous enough to sustain 50% long-term retention and a median session of nearly five hours. Revival and localization plays are worth exploring, as are licensing opportunities if the IP concept attracts cross-media partners. Current dev activity is strong, suggesting the studio remains invested. Most realistic play: revival.
- Risk: The deliberately offensive premise (gambling on infant mortality) may alienate broader audiences and complicate storefront visibility or platform partnerships.
- Risk: No Workshop support and minimal localization (English-only, Russian untranslated despite audience demand) suggest limited post-launch infrastructure investment.
- Risk: Player feedback indicates fatigue with post-launch content expansion; further additions may not grow the base and could splinter the existing compact community.
This case as Markdown · Estimates carry ±30-50% error per title.